January 2026
The global shock wave therapy market size is calculated at USD 2.32 billion in 2025 and is projected to hit around USD 6.48 billion by 2035 with a CAGR of 10.82%.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.73 billion in 2026 with a CAGR of 7.31%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The global aromatherapy market size surpassed USD 11.10 billion in 2026 and is estimated to reach around USD 23.31 billion by 2035, expanding at a CAGR of 8.61%.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.84 billion in 2026 with a notable CAGR of 5.66%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The plasma derived therapy market size is accounted at USD 25.01 billion in 2026 and is expected to hit around USD 45.29 billion by 2035 with a CAGR of 6.83%.
September 2026
The global T-cell therapy market size is reached at USD 13.99 billion in 2026 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
September 2026
The global gene therapy market size was exhibited at USD 13.24 billion in 2026 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
September 2026
The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
September 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
September 2026
The global physical therapy software market size is estimated to hit around USD 4.16 billion by 2035 growing from USD 1.70 billion in 2026, with a solid CAGR of 10.45%.
September 2026
The global radioembolization therapy market size was evaluated at USD 1.26 billion in 2026 and is predicted to hit around USD 2.15 billion by 2035, growing at a CAGR of 7.64%.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 9.39 billion in 2026, with a CAGR of 9.12%.
September 2026
The global wave and tidal energy market size is calculated at USD 704.78 million in 2026, and is projected to attain around USD 1,416.58 million by 2034 with a CAGR of 9.10%.
September 2026
The global cognitive behavioral therapy market size is expected to attain around USD 34.04 billion by 2034 from USD 10.48 billion in 2026 with a CAGR of 15.96%.
September 2026
The global microwave devices market size was calculated at USD 8.42 billion in 2024 and is predicted to worth around USD 14.89 billion by 2034 with a CAGR of 5.87%.
September 2026
The nicotine replacement therapy market generated USD 108.96 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
September 2026
The global personalized cell therapy market size was evaluated at USD 46.06 billion in 2026 and is predicted to reach around USD 235.65 billion by 2034, with a CAGR of 22.81%.
September 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 4.08 billion in 2026, with a CAGR of 27.55%.
September 2026
The global radiotherapy monitoring devices market size is estimated to hit around USD 2.48 billion by 2035 increasing from USD 1.29 billion in 2025, with a CAGR of 6.74%.
September 2026
The global advanced therapy medicinal products market size is projected to hit around USD 192.67 billion by 2035 increasing from USD 49.11 billion in 2026, with a CAGR of 16.44%.
September 2026
The global radiation therapy market size was estimated at USD 8.64 billion in 2026 and is expected to hit around USD 19.29 billion by 2035 with a CAGR of 9%.
September 2026
The global proton therapy market size surpassed USD 734.91 million in 2026 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
September 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com